NASDAQ NMS - GLOBAL MARKET · CMPX
+0.00% · +$0.0000 · Vol Not reported
Market closed · last close shown
Compass Therapeutics Inc.

Compass Therapeutics Inc.

Biotechnology
$2.40
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Earnings absence reason unknown · Analyst data unavailable at compute time
CMPX
Compass Therapeutics Inc.
Mon Aug 24 · last completed session · Markets closed · resumes Tue 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

47/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Mon Aug 24 · last completed session · Markets closed · resumes Tue 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CMPX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CMPX catalysts
About Compass Therapeutics Inc.
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2020
Employees
39
Country
US

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.40
Last session
Day high
$2.40
Last session
Day low
$2.40
Last session
Previous close
$2.40
52W high
$6.69
-64.13% from high
52W low
$1.67
15% of range
Market cap
$432.2M
EPS
$-0.1300
Beta
1.18
Shares out
180.1M
Avg volume
2.9M
VWAP
$2.40
Last session
Price history computed in-house
1W
+0.42%
1M
+15.94%
3M
+5.73%
1Y
-20.53%
YTD
-55.31%
SMA 50 $2.15 · above
SMA 200 $4.07 · below
52W position 15%

CMPX overview

Veridion Score
47
Registered · 2026-08-24
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around CMPX.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading CMPX Form 4 filings
Public disclosures

Congress activity in CMPX

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for CMPX in the cached public ledger.

Federal contracts

CMPX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CMPX in this window.
Lobbying spend

CMPX lobbying filings, year to date.

Registered lobbying filings matched to Compass Therapeutics Inc..

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CMPX in this window.
Loading news for CMPX
Analyst ratings
Sovereign unlock shows live analyst consensus for CMPX.
Options
Sovereign unlock shows live options positioning for CMPX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.